Abuse-Deterrent and Tamper-Resistant Opioid Formulations
- 1 October 2010
- journal article
- review article
- Published by Springer Nature in CNS Drugs
- Vol. 24 (10) , 805-810
Abstract
About one in every three individuals will experience chronic pain in their lifetime, and opioids are known to be an effective means to treat this condition. Much attention, however, has been given to...Keywords
This publication has 103 references indexed in Scilit:
- Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and AdolescentsJAMA, 2009
- A Naturalistic Study of Predictors and Risks of Atypical Antipsychotic Use in an Attention-Deficit/Hyperactivity Disorder ClinicJournal of Child and Adolescent Psychopharmacology, 2009
- Lack of Reduction in Buprenorphine Injection After Introduction of Co-Formulated Buprenorphine/Naloxone to the Malaysian MarketThe American Journal of Drug and Alcohol Abuse, 2009
- A retrospective evaluation of patients switched from buprenorphine (subutex) to the buprenorphine/naloxone combination (suboxone)Substance Abuse Treatment, Prevention, and Policy, 2008
- Attention-deficit/hyperactivity disorder, Tourette’s syndrome, and restless legs syndrome: The iron hypothesisMedical Hypotheses, 2008
- Approved and Investigational Uses of ModafinilDrugs, 2008
- REM-sleep alterations in children with co-existence of tic disorders and attention-deficit/hyperactivity disorder: impact of hypermotor symptomsEuropean Child & Adolescent Psychiatry, 2007
- Sleep-Disordered Breathing, Behavior, and Cognition in Children Before and After AdenotonsillectomyPediatrics, 2006
- Universal Precautions: A Matter of Mutual Trust and ResponsibilityPain Medicine, 2006
- Dopaminergic therapy in children with restless legs/periodic limb movements in sleep and ADHDPediatric Neurology, 2000